Streetbeat News

Equity Actions

GHLD

Guild Holdings shares dropped following disappointing Q4 revenue results. The company also extended its share repurchase program until May 5th.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:33 pm

GHLD

The board of Guild Holdings Company extended its share repurchase program until May 5, indicating confidence in the company's financial health and potentially signaling a positive outlook to investors.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:32 pm

LYV

SSSS

Liquid Death, a rapidly growing beverage company, announced a new funding round of $67 million, reaching a valuation of $1.4 billion. The company, known for its canned water, flavored sparkling water, and iced tea, has attracted new investors including SuRo Capital (NASDAQ:SSSS) and Live Nation Entertainment (NYSE:LYV), along with celebrity investors like Josh Brolin and DeAndre Hopkins. The funding will support product innovation and operational scaling. Liquid Death reported $263 million in retail sales in 2023 and has expanded to 113,000 retail locations in the US and UK.

Portfolio Pulse from Chris Katje

March 12, 2024 | 8:27 pm

COIN

Coinbase Global, Inc. (NASDAQ:COIN) plans to offer $1B in Convertible Senior Notes due 2030 to qualified institutional buyers, with an option for an additional $150M to cover over-allotments. The notes, maturing on April 1, 2030, will be senior, unsecured obligations convertible into cash, shares, or a combination. Terms will be set upon pricing. Coinbase also aims to enter capped call transactions to reduce potential dilution or offset cash payments required upon conversion, subject to a cap.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:24 pm

ICHR

Ichor Holdings, Ltd. has announced a public offering of its ordinary shares, aiming to raise $125 million. This move could potentially dilute existing shareholders but also provide the company with significant capital for operations, investments, or debt reduction.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:21 pm

SKIN

The Beauty Health Company (NASDAQ:SKIN), known for its flagship brand Hydrafacial, has officially appointed Marla Beck as its President and CEO. Beck, who has been serving as Interim CEO since November 20, 2023, and is a member of the Board of Directors, brings extensive experience from her time as the founder and CEO of Bluemercury. Her leadership is expected to drive growth and value for BeautyHealth, leveraging her deep understanding of the beauty industry and track record of building successful brands.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:07 pm

AAPL

Stephanie Link of Hightower Advisors has increased her stake in Apple Inc (AAPL), citing the stock's current valuation as a bargain. Despite a 13% drop from its highs and weak iPhone sales in China, Link believes Apple will outperform this quarter due to expected better-than-anticipated April quarter results, strong services business growth, and robust margins. She anticipates a new buyback announcement in the upcoming second-quarter results, which, along with a focus on AI at the Worldwide Developers Conference in June, could further support the stock. Apple's stock is trading at a lower P/E ratio compared to its historical average, making it an attractive investment according to Link.

Portfolio Pulse from Adam Eckert

March 12, 2024 | 7:38 pm

ARKK

COIN

ROKU

SARK

TARK

TSLA

The AXS 2X Innovation ETF (TARK) is trading within a symmetrical triangle pattern, influenced by its largest holding, Coinbase (COIN), which has surged 124% since Feb. 7. TARK aims to return 200% of the daily performance of the ARK Innovation ETF (ARKK), which has been supported by the Bitcoin rally. ARKK's other top holdings, Tesla (TSLA) and Roku (ROKU), have underperformed, falling about 30% each since the start of the year. TARK is expected to break from the pattern by March 18, indicating future direction. Bearish traders can consider the AXS Short Innovation Daily ETF (SARK), which inversely tracks ARKK.

Portfolio Pulse from Melanie Schaffer

March 12, 2024 | 7:34 pm

ASLN

ASLAN Pharmaceuticals' stock price has decreased following the announcement of a $5 million registered direct offering. This move indicates the company is seeking to raise capital, potentially diluting existing shareholders' equity.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 7:28 pm

ASLN

ASLAN Pharmaceuticals has announced a $5 million registered direct offering. This financial move could indicate the company's strategy to raise capital, potentially for research, development, or operational expansion.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 7:17 pm